On estimands in target trial emulation
By: Edoardo Efrem Gervasoni , Liesbet De Bus , Stijn Vansteelandt and more
Potential Business Impact:
Helps doctors understand how treatments change over time.
The target trial framework enables causal inference from longitudinal observational data by emulating randomized trials initiated at multiple time points. Precision is often improved by pooling information across trials, with standard models typically assuming - among other things - a time-constant treatment effect. However, this obscures interpretation when the true treatment effect varies, which we argue to be likely as a result of relying on noncollapsible estimands. To address these challenges, this paper introduces a model-free strategy for target trial analysis, centered around the choice of the estimand, rather than model specification. This ensures that treatment effects remain clearly interpretable for well-defined populations even under model misspecification. We propose estimands suitable for different study designs, and develop accompanying G-computation and inverse probability weighted estimators. Applications on simulations and real data on antimicrobial de-escalation in an intensive care unit setting demonstrate the greater clarity and reliability of the proposed methodology over traditional techniques.
Similar Papers
Incorporating estimands into meta-analyses of clinical trials
Applications
Helps doctors combine study results better.
Bayesian Semiparametric Causal Inference: Targeted Doubly Robust Estimation of Treatment Effects
Methodology
Finds true effects from messy data.
Target trial emulation without matching: a more efficient approach for evaluating vaccine effectiveness using observational data
Methodology
Finds better ways to test vaccine success.